Regeneron Pharmaceuticals logo

Regeneron Pharmaceuticals Share Price Today

(NASDAQ: REGN)

Regeneron Pharmaceuticals share price is $620.9 & ₹53,163.94 as on 2 Apr 2025, 01.01 hrs IST

$620.9

-13.33

(-2.1%)

Live

View live Regeneron Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Regeneron Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Regeneron Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Regeneron Pharmaceuticals share price movements

  • Today's Low: $620.90
    Today's High: $640.81

    Day's Volatility :3.11%

  • 52 Weeks Low: $618.51
    52 Weeks High: $1,211.20

    52 Weeks Volatility :48.93%

Regeneron Pharmaceuticals (REGN) Returns

PeriodRegeneron Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-10.96%
6.1%
0.0%
6 Months
-39.42%
-4.7%
0.0%
1 Year
-34.57%
-0.3%
0.0%
3 Years
-9.19%
5.8%
-15.4%

Regeneron Pharmaceuticals (REGN) Key Statistics

in dollars & INR

Previous Close
$634.23
Open
$630.08
Today's High
$640.81
Today's Low
$617.4
Market Capitalization
$69.7B
Today's Volume
$1.1M
52 Week High
$1211.1999
52 Week Low
$618.505
Revenue TTM
$14.2B
EBITDA
$4.6B
Earnings Per Share (EPS)
$38.37
PE Ratio
16.53
Dividend Yield
0.56%
Profit Margin
31.07%
Quarterly Earnings Growth YOY
-0.21%
Return On Equity TTM
15.95%

How to invest in Regeneron Pharmaceuticals Stock (REGN) from India?

It is very easy for Indian residents to invest directly in Regeneron Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Regeneron Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Regeneron Pharmaceuticals or REGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Regeneron Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Regeneron Pharmaceuticals shares which would translate to 0.001 fractional shares of Regeneron Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Regeneron Pharmaceuticals, in just a few clicks!

Returns in Regeneron Pharmaceuticals (REGN) for Indian investors in Rupees

The Regeneron Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Regeneron Pharmaceuticals investment value today

Current value as on today

₹66,761

Returns

₹33,239

(-33.24%)

Returns from Regeneron Pharmaceuticals Stock

₹35,944 (-35.94%)

Dollar Returns

₹2,705 (+2.7%)

Indian investors sentiment towards Regeneron Pharmaceuticals (REGN)

24.48%

Period: Mar 1, 2025 to Mar 31, 2025. Change in 30 Days versus previous period

Investment in Regeneron Pharmaceuticals Shares from India has grown by 24.48% over the past 30 days, indicating increased transactional activity.

-29%

Period: Mar 1, 2025 to Mar 31, 2025. Change in 30 Days versus previous period

Search interest for Regeneron Pharmaceuticals Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Regeneron Pharmaceuticals Stock (REGN Ticker)

Global Institutional Holdings in Regeneron Pharmaceuticals

  • Vanguard Group Inc

    8.49%

  • BlackRock Inc

    7.99%

  • FMR Inc

    7.50%

  • JPMorgan Chase & Co

    6.46%

  • State Street Corp

    4.42%

  • Capital Research & Mgmt Co - Division 3

    4.33%

Analyst Recommendation on Regeneron Pharmaceuticals

Buy

    76%Buy

    20%Hold

    2%Sell

Based on 34 Wall street analysts offering stock ratings for Regeneron Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 34 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
26
26
26
Hold
7
7
5
Sell
1
1
1

Analyst Forecast on Regeneron Pharmaceuticals Stock (REGN)

What analysts predicted

Upside of 48.66%

Target:

$923.05

Current:

$620.90

Insights on Regeneron Pharmaceuticals Stock (Ticker Symbol: REGN)

  • Price Movement

    In the last 6 months, REGN stock has moved down by -39.4%
  • Increasing Revenue

    Regeneron Pharmaceuticals, Inc. has shown consistent revenue growth over the last four quarters, increasing from $3.14 billion to $3.78 billion. This represents an average quarterly increase of 5.9%.
  • Decreasing Net Profit

    Regeneron Pharmaceuticals, Inc. has seen a decline in its net profit over the last three quarters. It decreased from $1.43 billion to $917.7 million, averaging a reduction of 19.0% each quarter.
  • REGN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 76.1% return, outperforming this stock by 110.7%
  • REGN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 59.5% return, outperforming this stock by 68.2%
  • Price to Sales

    Regeneron Pharmaceuticals, Inc. has a Price-to-Sales Ratio of 4.8. This means that for every $1 of sales Regeneron generates, investors are willing to pay $4.8. In comparison, Alnylam Pharmaceuticals, Inc. has a much higher Price-to-Sales Ratio of 15.3, indicating that investors are willing to pay $15.3 for every $1 of sales from Alnylam. This suggests that investors view Alnylam's sales as more valuable compared to those of Regeneron.

Regeneron Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Regeneron Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Regeneron Pharmaceuticals (REGN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Regeneron Pharmaceuticals, Inc. logo
-7.39%
-39.42%
-34.57%
-9.19%
27.16%
Beone Medicines Ltd logo
10.85%
17.83%
70.93%
25.98%
99.6%
Vertex Pharmaceuticals Incorporated logo
0.31%
3.21%
15.3%
80.47%
100.21%
Alnylam Pharmaceuticals, Inc. logo
10.88%
-2.19%
76.1%
66.92%
159.11%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Regeneron Pharmaceuticals, Inc. logo
16.53
16.53
0.95
42.58
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.45
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.4
18.04
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.82
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Regeneron Pharmaceuticals, Inc. logo
Buy
$69.7B
27.16%
16.53
31.07%
Beone Medicines Ltd logo
NA
$30.1B
99.6%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$126.5B
100.21%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.9B
159.11%
NA
-12.37%

Regeneron Pharmaceuticals Dividend announcements

  • Regeneron Pharmaceuticals Dividends March, 2025

    In the quarter ending March,2025. Regeneron Pharmaceuticals has declared dividend of $0.88

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; and with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Organization
Regeneron Pharmaceuticals
Employees
15106
CEO
Dr. Leonard S. Schleifer M.D., Ph.D.
Industry
Health Technology

Management People of Regeneron Pharmaceuticals

NameTitle
Dr. Leonard S. Schleifer M.D., Ph.D.
Co-Founder, President, CEO & Co-Chairman
Dr. George D. Yancopoulos M.D., Ph.D.
Co-Founder, President, Chief Scientific Officer & Co-Chairman
Dr. Andrew J. Murphy Ph.D.
Executive Vice President of Research
Mr. Daniel P. Van Plew
Executive VP and GM of Industrial Operations & Product Supply
Mr. Christopher R. Fenimore CPA
Executive VP of Finance & CFO
Ms. Patrice Gilooly
Senior Vice President of Quality Assurance & Operations
Mr. Bob McCowan
Senior VP of IT & Chief Information Officer
Mr. Ryan Crowe
Senior Vice President of Investor Relations & Strategic Analysis
Mr. Joseph J. LaRosa J.D.
Executive VP, General Counsel & Secretary
Ms. Melissa Lozner
Senior VP & Chief Compliance Officer

Important FAQs about investing in REGN Stock from India :

What is Regeneron Pharmaceuticals share price today?

Regeneron Pharmaceuticals share price today stands at $620.90, Open: $630.08 ; Previous Close: $634.23 ; High: $640.81 ; Low: $620.90 ; 52 Week High: $1,211.20 ; 52 Week Low: $618.51.

The stock opens at $630.08, after a previous close of $634.23. The stock reached a daily high of $640.81 and a low of $620.90, with a 52-week high of $1,211.20 and a 52-week low of $618.51.

Can Indians buy Regeneron Pharmaceuticals shares?

Yes, Indians can invest in the Regeneron Pharmaceuticals (REGN) from India.

With INDmoney, you can buy Regeneron Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Regeneron Pharmaceuticals at zero transaction cost.

How can I buy Regeneron Pharmaceuticals shares from India?

It is very easy to buy Regeneron Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Regeneron Pharmaceuticals (REGN) be purchased?

Yes, you can buy fractional shares of Regeneron Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Regeneron Pharmaceuticals stocks?

To start investing in Regeneron Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Regeneron Pharmaceuticals Stock (REGN)?

Today’s highest price of Regeneron Pharmaceuticals (REGN) is $640.81.

Today’s lowest price of Regeneron Pharmaceuticals (REGN) is $620.90.

What is today's market capitalisation of Regeneron Pharmaceuticals?

Today's market capitalisation of Regeneron Pharmaceuticals REGN is 69.7B

What is the 52 Week High and Low Range of Regeneron Pharmaceuticals Stock (REGN)?

  • 52 Week High

    $1,211.20

  • 52 Week Low

    $618.51

What are the historical returns of Regeneron Pharmaceuticals (REGN)?

  • 1 Month Returns

    -7.39%

  • 3 Months Returns

    -39.42%

  • 1 Year Returns

    -34.57%

  • 5 Years Returns

    27.16%

Who is the Chief Executive Officer (CEO) of Regeneron Pharmaceuticals ?

Dr. Leonard S. Schleifer M.D., Ph.D. is the current Chief Executive Officer (CEO) of Regeneron Pharmaceuticals.